Guidance for Providers Offering Misoprostol-Alone for Abortion Amidst COVID-19

In response to an outspoken need around the world, Gynuity Health Projects and CEDES, in collaboration with Médecins Sans Frontières, ASAP, CLACAI, REDAAS and Women Help Women, have developed a resource for providers who have access to misoprostol to ensure that safe medical abortion can still be offered during the COVID-19 pandemic and in accordance with social distancing practices. The guidance reviews the steps of providing misoprostol medical abortion and makes evidence-based recommendations for limiting contact and reducing in-person visits.

The guidance is available in a mobile-optimized format for viewing on a mobile phone or tablet, as well as in a more traditionally-sized printable format.

It is currently available in English and Spanish and will also be available in French, Russian and Arabic.